Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 12,050 | 5,100 | 18,900 | 16,600 | 4,500 |
| Gross Profit | 12,050 | 5,100 | 18,900 | 16,600 | 4,500 |
| Operating Expenses | 12,088 | 17,000 | 18,763 | 14,988 | 9,416 |
| Operating Income | -38 | -11,900 | 137 | 1,612 | -4,916 |
| Interest Expense | 97 | 230 | 128 | 212 | 752 |
| Other Income | 569 | 960 | 1,092 | 832 | 261 |
| Pre-tax Income | 435 | -11,170 | 1,101 | 2,232 | -5,407 |
| Income Tax | N/A | 0 | 90 | 510 | 532 |
| Net Income Continuous | 435 | -11,173 | 1,011 | 1,722 | -5,939 |
| Net Income | $435 | $-11,170 | $1,011 | $1,722 | $-5,939 |
| EPS Basic Total Ops | 1,978.62 | -51,443.34 | 4,748.74 | 7,518.81 | -36,407.04 |
| EPS Basic Continuous Ops | 1,946.59 | -55,865.00 | 5,055.00 | 8,610.00 | -36,407.04 |
| EPS Diluted Total Ops | 1,978.62 | -51,443.34 | 4,352.92 | 7,518.81 | -36,407.04 |
| EPS Diluted Continuous Ops | 1,917.73 | -55,865.00 | 5,055.00 | 8,610.00 | -36,407.04 |
| EBITDA(a) | $555 | $-11,070 | $730 | $2,072 | $-4,488 |